Biogen Inc Drug Patent Portfolio

Biogen Inc's Family Patents

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Alzheimer's medication research draws inspiration from cancer treatment strategies that focus on multiple targets - The Japan Times

12 Dec, 2025

Lessons from Cancer Treatment Applied to Alzheimer's: A Multi-Target Drug Approach - OC Academy

12 Dec, 2025

Biogen and Stoke Enhance the Promising Market Potential of Their Epilepsy Medication with Initial Findings on Seizure Reduction

08 Dec, 2025

ANDA Litigation Settlements for Q3 2025 | Robins Kaplan LLP - JDSupra

30 Oct, 2025